Brief: Acelrx Pharmaceuticals Announces Divestment Of Dsuvia® To Alora Pharmaceuticals
March 14 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS ANNOUNCES DIVESTMENT OF DSUVIA® TO
ALORA
PHARMACEUTICALS
* ACELRX - AGREEMENT PROVIDES CO WITH 15% ROYALTY ON
COMMERCIAL
SALES OF DSUVIA, 75% ROYALTY ON SALES OF DSUVIA TO DEPARTMENT OF
DEFENSE
* ACELRX PHARMACEUTICALS INC - AGREEMENT PROVIDES ACELRX
WITH AND
UP TO $116.5 MILLION IN SALES-BASED MILESTONES
Source text for Eikon: ID:nPn8hphrHa
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial